Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Optical control of carrier-mediated ion transport by photoswitchable lipids

Juergen Pfeffermann a, Rohit Yadav a, Toma Glasnov b, Oliver Thorn-Seshold c and Peter Pohl *a
aInstitute of Biophysics, Johannes Kepler University Linz, Linz, Austria. E-mail: peter.pohl@jku.at
bInstitute of Chemistry, University of Graz, Graz, Austria
cFaculty of Chemistry and Food Chemistry, Dresden University of Technology, Dresden, Germany

Received 7th October 2025 , Accepted 3rd December 2025

First published on 4th December 2025


Abstract

We report a molecular strategy for precise, reversible, and noninvasive photoregulation of ion-selective membrane transport. Embedding azobenzene-containing photolipids into bilayers enables nanoscale control over the interaction and mobility of small-molecule ion carriers. Photoisomerization alone produces only minor changes in baseline conductance, consistent with the limited influence of small bilayer thickness variations on ion permeability, yet it elicits striking responses in the presence of mobile carriers. A newly designed protonophore exhibits proton-selective currents that increase by up to 200-fold under UV illumination and revert to baseline within milliseconds upon blue light. These effects cannot be explained by thickness or fluidity changes. Instead, they arise from light-dependent interactions between azobenzene moieties and the carrier that increase the membrane-bound carrier concentration and lower the effective barrier for transbilayer permeation via interfacial dipole and packing modulation. Because this mechanism relies entirely on chemical design – without genetic modification – and is compatible with photoswitches operating at longer wavelengths, it establishes a versatile framework for dynamic, light-driven control of ion transport in biological membranes and synthetic nanosystems.


Introduction

The regulated transport of ions across biological membranes is central to cellular function. In excitable cells, rapid changes in sodium and potassium permeability enable neuronal signaling,1 while in energy metabolism, regulated proton flux sustains ATP synthesis and limits reactive oxygen species generation.2,3 Achieving precise and reversible control of ion-selective transport by external stimuli is a key goal in both fundamental biophysics and applied nanomaterials research.

Light is particularly attractive because it affords site-specific, minimally invasive, temporally precise, and reversible control over membrane conductance and permeability.4–6 The membrane permeability coefficient P relates steady-state ion flux J to the transmembrane concentration gradient Δc as J = −P·Δc.7 Classical theory (Fig. 1a) established that small changes in bilayer thickness or ion pairing have limited impact on P, whereas nanoscale carriers and channels can dramatically enhance ion translocation by providing polar pathways and reducing the Born energy penalty.8,9


image file: d5nr04234h-f1.tif
Fig. 1 Components and concepts underlying photolipid-regulated nanoscale carrier transport. (a) Channels and nanoscale carriers facilitate transmembrane ion transport across biological membranes along the electrochemical gradient.8 Carrier transport typically occurs in four steps: 1, an ion at the bilayer–aqueous interface associates with an interfacially-adsorbed carrier molecule; 2, the carrier–ion complex traverses the membrane; 3, the ion dissociates from the carrier and is released into the membrane's aqueous surroundings; 4, the free carrier can traverse the membrane as well; it is free to bind another ion or recycle to the original side. (b) The photolipid OptoDArG in its trans and cis state: blue light (488 nm) generates mainly the former, UV light (375 nm) generates mainly the latter. For brevity, the photoequilibria will henceforth be indicated as simply “trans” (blue light) and “cis” (UV light). cis-OptoDArG is broader and shorter than trans-OptoDArG. (c) Both photoisomers incorporate into lipid bilayers and cellular membranes. Photoisomerization of membrane-embedded photolipids causes changes in global material properties owing to changes in molecular structure (cf. panel b). Structurally, photoisomerization to cis-OptoDArG by UV light increases bilayer surface area but reduces bilayer thickness. (d) Chemical structures of the carriers used in this study: the cationic K+ ionophore valinomycin, the anionic protonophore CCCP and NB-lipid, a lipidated Nile Blue derivative which acts as a cationic protonophore. (e) cis-azobenzene has a dipole moment, image file: d5nr04234h-t4.tif of magnitude 3 D; δ and δ+ indicate negative and positive partial charge. A simplified view of the expected orientation of cis-OptoDArG in the lipid bilayer (cf. panel c) indicates that, on average, the azobenzene moieties’ dipole moments point towards the interfaces.

Here, we show that nanoscale photolipid dopants couple light-induced conformational changes to carrier-mediated ion transport. Beyond the established thickness modulation from azobenzene photoisomerization, photolipid incorporation produces pronounced changes in carrier-induced conductivity by: (i) modifying interfacial packing, (ii) creating conformation-dependent interfacial binding sites for the carrier, and (iii) lowering the effective barrier for flip-flop and transbilayer passage via interfacial dipole potential and packing modulation. This establishes a molecular platform for reversible, optical switching of ion transport across synthetic and biological membranes, compatible with photoswitches operating at longer wavelengths.6,10,11

Regulation of valinomycin–K+ flux across photoswitchable bilayers

Our approach leverages previous findings that the photolipid OptoDArG (Fig. 1b) spontaneously incorporates into lipid bilayers and can undergo rapid isomerization there by exposure to intense UV (375 nm) or blue (488 nm) light (irradiance of several hundred W cm−2).12 Consequent changes in molecular structure alter the material properties of the embedding bilayer membrane at the millisecond scale (Fig. 1c).12,13 We conducted initial experiments with the electrically neutral dodecadepsipeptide macrocycle valinomycin (Fig. 1d) synthesized by Streptomyces fulvissimus.14 Valinomycin can traverse the membrane both as a neutral molecule without K+ and as a valinomycin–K+ complex,9,15 thus acting as an established K+-selective carrier (Fig. 1a).9,15

Using voltage-clamp measurements on photolipid-containing planar lipid bilayers (PLBs; folded from 80 wt% E. coli polar lipid extract (PLE) with 20 wt% OptoDArG; schematic of the experimental setup in Fig. 2a) in the presence of 10 µM valinomycin, we observed an increase in current, I, within milliseconds of UV light exposure (Fig. 2b). To calculate membrane conductance g0 at V = 0 mV, we fitted the equation I(V) = g0·(1 + αV2)·V + o to the current–voltage (IV) curves recorded under symmetric conditions (Fig. 2c) where I(V) is the current at a particular voltage, g0 the conductance at V = 0 mV and α is a supralinearity factor;7o accounts for a small current offset. g0 was sensitive to illumination. The ratio g0,UV/g0,blue was 7.5 ± 1.1 (mean ± SEM, N = 4), where g0,UV denotes the conductivity at 0 mV following photoisomerization to the photostationary cis state induced by UV light and g0,blue the conductivity at 0 mV following photoisomerization back to the photostationary trans state induced by blue light. Light sensitivity was conferred by OptoDArG, as indicated by the small value of g0,UV/g0,blue = 1.2 (compare recordings of I in Fig. S2c), the latter likely reflecting minor changes in membrane temperature (a related observation in ref. 16).


image file: d5nr04234h-f2.tif
Fig. 2 Photoisomerization of photoswitchable PLBs regulates the flux of valinomycin–K+ across the membrane. (a) Schematic of the measurement setup. The patch-clamp amplifier was used to clamp a transmembrane potential, V, across the horizontal PLB and measure the ensuing current, I. A blue and UV laser were used to rapidly isomerize the photoswitchable PLB. The resulting changes in carrier current at constant electrochemical driving force are measured. Side 1 and side 2 are indicated. (b) Voltage–clamp current, I, recordings on a photoswitchable planar lipid bilayer (PLB) with 10 µM valinomycin added to the aqueous compartments (15 mM KCl, 10 mM HEPES pH 7.4) on both sides. Voltage protocol (inset above): between 0 and 50 ms, V = 0 mV and between 50 and 300 ms, V = 130 mV to −130 mV with 20 mV steps between separate sweeps; the delay between consecutively recorded sweeps was 1 s. As indicated, the PLB was exposed to UV light between 100 and 150 ms (magenta bar) and to blue light between 200 and 250 ms (blue bar). UV light evokes a rapid increase in I that is effectively abrogated by blue light exposure. (c) IV curves constructed from current traces recorded as in panel b by averaging I within certain time intervals and plotting the obtained values over V. IUV values were calculated by averaging I between 125 and 150 ms (magenta squares); Iblue values by averaging I between 225 and 250 ms (blue circles). IV curves are given for symmetric (15 mM KCl at both sides, closed symbols) and asymmetric ionic conditions (150 mM KCl at side 1, 15 mM KCl at side 2, open symbols). The K+ selectivity is retained upon UV light exposure.

IV curves constructed from measurements under a 10-fold K+ concentration gradient (open symbols in Fig. 2c) resulted in reversal potentials, Vr, of −56.5 mV (trans state) and −59.8 mV (cis state; both determined by interpolation), which is close to −59 mV anticipated from the Nernst equation. This shows that the selectivity of valinomycin for K+ was retained. We determined that, with variation of the UV laser power (Fig. S1b), the fit values for the rate of current increase linearly with irradiance (Fig. S1c), which is also true for the rate of capacitance change.12 The increase in I with UV light was clearly the result of photolipid photoisomerization, as evidenced by its abrogation by blue light (at 200 ms in Fig. 2b; rate ≈ 7000 s−1) which isomerizes the azobenzenes in OptoDArG's acyl chains back to the trans state. The UV-evoked increase in I does not spontaneously decay to the pre-UV-illumination level without exposure to blue light. This is emphasized by Fig. S1a in which UV light was applied but no blue light and I stayed high. Consequently, we conclude that heating or photodynamic effects did not play a determining role but that changes in bilayer properties that are associated with reversible photolipid photoisomerization did.

To account for the several-fold increment in g0,UV/g0,blue, we employ a modified Nernst-Planck equation in the small potential limit (compare eqn (72) in ref. 7):

 
image file: d5nr04234h-t1.tif(1)
where F, R, and T denote the Faraday constant, universal gas constant, and absolute temperature, respectively. In the following, we restrict our analysis to monovalent ions, so the valence z is unity and will be omitted for clarity. Eqn (1) describes the functional dependence of g0 on P. For reasons outlined below, we assume a three-slab model of the lipid bilayer: the outer slabs represent the headgroup regions, the inner slab corresponds to the hydrophobic membrane core. Accordingly, eqn (1) describes the permeation through the inner slab, and [S] denotes the concentration of the charged species in the outer slabs – i.e., after partitioning into the headgroup region, but with the charge still oriented toward the adjacent aqueous phase. In this model, P may be represented as P = Kp·D/d, where D is the membrane diffusion coefficient, and d membrane thickness. The partition coefficient Kp which characterises the transfer of species S from one of the outer slabs into the inner slab (onto the top of the trapezoidal energy barrier), can be rewritten in terms of a Boltzmann distribution involving the free energy ΔG that opposes transmembrane movement. Substituting these expressions yields:
 
image file: d5nr04234h-t2.tif(2)

Eqn (2) does not allow to explain the roughly eightfold increase in g0 by alterations of d or D or a combination of both. d does not change by more than 10% upon photoisomerization, even if we attribute the entire 10% change in capacitance (Fig. S5b) to d. D is also unlikely to change strongly in fluid membranes – it has long been recognized that the diffusion coefficients contribute only marginally to membrane permeability differences, with partition coefficients playing the dominant role.17 Molecular dynamics simulations confirmed this finding for a weak base, even in cholesterol-containing membranes.18

Considering photoinduced changes in the dielectric constant, εhc, and the resulting alterations in ΔG as a possible origin of the increase in g0 yields similarly unsatisfying results. εhc affects ΔG because electrostatic terms constitute the major contributions to ΔG. These include (i) ion self-hydration given by the Born energy, ΔGb, and (ii) interaction with the positive membrane dipole potential, ϕd, giving rise to the dipole energy term, ΔGd, which is sensitive to the ion's sign.19 Remaining minor contributions include image forces and the energy required to insert the neutral species into the bilayer. To assess how strongly ΔG may be altered by changes in εhc we rely on two observations: (i) the electrostatic components of ΔG are inversely proportional to εhc, and (ii) the Arrhenius activation energy Ev = 16 kcal mol−1 (ref. 20) being proportional to the unknown ΔG enables the use of Expression 2 to predict the expected tenfold change in g0 if illumination alters εhc by 10%. In our assessment, we attribute the entire increase in capacitance observed upon UV illumination to a rise in εhc from 2.1 to 2.3. As a result, the inversely proportional Ev is expected to decrease to approximately 14.6 kcal mol−1.

Yet, even such modest changes in εhc should be ruled out, as the permeability to other ions did not show similar changes. Since their conductance is also sensitive to changes in εhc,21 we would have expected larger differences in g0 between the trans and cis bilayer states for inorganic ions such as Cl and for organic anions like tetraphenylborate (TPB). Specifically, literature reports suggest ΔG ≈ 23.6 kcal mol−1 for Cl permeation.22 Using the same logic as above, a 10% increase in εhc would lower ΔG to ≈21.5 kcal mol−1 and, via Expression 2, increase g0 by ≈35-fold. However, photoisomerization of OptoDArG led to only a modest increase in the background Cl conductance – from 12.1 ± 0.8 pS in the trans state to 20.7 ± 0.8 pS in the cis state (Fig. 3a). Although the resulting 71% increase was notable, it remained several-fold smaller than the ≈35-fold increase predicted by changes in εhc, reinforcing that photoisomerization-evoked changes in dielectric constant are not the principal driver of the observed conductance changes with valinomycin–K+ complexes.


image file: d5nr04234h-f3.tif
Fig. 3 Photoisomerization has a comparatively small effect on background and hydrophobic ion conductance. (a) To infer the change in background ion conductance upon photoisomerization, recordings as in Fig. 2b but in the absence of carrier were conducted; the buffer was 15 mM KCl, 10 mM HEPES pH 7.4. IV curves were constructed from the obtained records, as described in Fig. 2c, and data points from 5 separately prepared experiments were averaged (error bars correspond to SD). The curves were fit by linear models with offset, with each point weighted by 1/SD2 (R2 of 0.97 [cis state] and 0.96 [trans state]). Background ion conductance increases by ≈71% in the bilayer cis state, a small effect compared to the experiments with valinomycin and CCCP. (b) Tetraphenylborate (TPB) is a hydrophobic anion that permeates the membrane. At low bulk TPB concentrations, voltage application leads to the redistribution of membrane-adsorbed ions between the leaflets without considerable contribution from the bulk.23 Hence, in contrast to carriers, chemical uptake and release reactions at the interface play little role (cf. Fig. 1a). (c) Transient TPB currents evoked upon the application of V = 120 mV at t = 0 s with the bilayer in the cis (magenta lines) or trans state (blue lines); TPB was 200 nM in 100 mM NaCl, 10 mM HEPES pH 7.4 (conditions similar to ref. 23). Each transient was recorded twice with a delay of 800 ms to check for steady-state conditions: the curves overlap perfectly. Due to a 2 MΩ resistance in series with the PLB, necessary for capacitance compensation, and the deployed 10 kHz Bessel filter, the transients are smoothed. Hence, to estimate initial current I0 and decay time τ, data points from 1 to 8 ms were fit with a monoexponential model. The fits (red lines) indicate a modest effect (around 2-fold) of bilayer state on I0 and τ, which is small compared to the experiments with valinomycin and CCCP.

Second, we assessed the photoeffects on TPB-mediated conductivity. Its membrane permeability is much higher than that of inorganic ions.23,24 It is so large that the diffusion of TPB towards the membrane limits the steady-state current. At the TPB concentrations used (200 nM), application of a voltage (V = 120 mV at t = 0 ms in Fig. 4c) leads to the redistribution of membrane-adsorbed TPB between the adsorption sites in each leaflet (schematic in Fig. 4b), which results in an exponentially decaying current.23 A monoexponential fit to the transient currents in Fig. 4c allowed us to estimate the initial current, I0, and time constant of the transient, τ.24 Both parameters increase by a factor of ≈2 in the cis state membrane (inset in Fig. 4c). This indicates that the flux between the adsorption sites increases in the presence of cis-OptoDArG, but the increase is small compared to the effects on valinomycin–K+. From these observations, we conclude that εhc-mediated flux amplifications cannot govern the photoeffect on valinomycin–K+ currents.


image file: d5nr04234h-f4.tif
Fig. 4 The transmembrane flux of the anionic protonophore CCCP is rapidly modulated by photoisomerization of membrane-embedded photolipids. (a) Voltage–clamp current recordings on a photoswitchable PLB with 10 µM CCCP added to the aqueous compartments (100 mM KCl, 20 mM HEPES pH 7.0) on both sides. The recordings were made as in Fig. 2b. As with valinomycin–K+, I increases upon UV light exposure and blue light reverts this increment. That is, the flux of CCCP is increased across the cis state membrane. (b) IV curves constructed as described in Fig. 2c for recordings under symmetric (pH 7 at both sides; closed symbols) and asymmetric conditions (pH 5 at side 1, pH 7 at side 2; open symbols). Upon creating the gradient in pH by the addition of HCl to compartment 1, Vr shifted towards large negative values, consistent with proton-selective transport. Whilst exposure to UV light increased I, it remained selective for H+. (c) Photoswitchable PLB with 2.5 µM CCCP added to the aqueous compartments (15 mM KCl, 10 mM HEPES pH 7.4) on both sides. Voltage protocol as in panel a. In contrast to panel a, UV light exposure between 100 and 150 ms was immediately followed by blue light from 150 to 200 ms. This record shows that blue light leads to the immediate abrogation of the UV-evoked increment in I as a result of switching back to the trans bilayer state.

With changes in εhc excluded as the source of the photoinduced modulation of ΔG (Expression 2), we considered an alternative explanation: variations in the membrane dipole potential, ϕd, leading to changes in ΔGb. Primarily generated by phospholipid carbonyl groups and ordered interfacial water, ϕd (typically around +250 mV inside the membrane) opposes cation partitioning and favors anion partitioning.25,26 Permeability differences between structurally similar organic cations and anions can span up to seven orders of magnitude.25 A decrease in ϕd by several tens of millivolts could plausibly increase valinomycin–K+ permeation by an order of magnitude.27 Such a reduction might arise from (i) dipole moment differences between cis- and trans-azobenzenes in OptoDArG (Fig. 1e),28 (ii) looser lipid packing due to the larger footprint of cis-OptoDArG (Fig. 1c), or (iii) altered orientation or density of interfacial water.29 However, our TPB data argue against this mechanism. While reduced ϕd would align with increased valinomycin conductance, it cannot account for the observed doubling of TPB conductance; in fact, it should have decreased. These findings thus rule out ϕd changes as the main driver of the ≈10-fold increase in g0 for valinomycin–K+ upon UV-induced cis-OptoDArG formation (Fig. 3).

As ΔG does not explain the increase in g0 and changes in D or d were excluded previously, [S] remains the only plausible factor in eqn (1). The much larger current increase for valinomycin–K+ compared to TPB suggests a mechanistic distinction: valinomycin reversibly binds K+ at the membrane interface. This process is governed by (i) association and dissociation rate constants kA and kD, respectively, with their ratio KA = kA/kD defining the equilibrium constant, and (ii) valinomycin partitioning from the aqueous solution into the membrane. In the absence of photolipids, both KA and valinomycin partitioning were found to depend on acyl chain length and unsaturation.30KA increased from 1.5 in membranes with monounsaturated oleoyl (C18:1) chains to 9 with polyunsaturated linolenoyl (C18:3) chains. Since the transcis isomerisation of the photolipid mimics the changes in headgroup spacing observed with increasing unsaturation, we expect a higher KA in cis bilayers. As a consequence, [S] increases and thus I, even when translocation remains rate-limiting. In other words, the resulting accumulation of valinomycin–K+ complexes enhances transmembrane K+ flux. The observed increase in valinomycin–K+ current through cis-state PLBs closely matches the previously reported sixfold rise in KA,30 lending credibility to this mechanism.

Regulation of CCCP flux across photoswitchable bilayers

The mechanism identified above for valinomycin suggests that chiefly those ionophores or protonophores for which an increase in KA can be expected should be affected by the photolipid's conformational change. This likely excludes the protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP), as it is well established that CCCP protonation is diffusion-limited,31 effectively disavowing a phototriggered increase in the equilibrium constant KA and the surface pKa.

We were therefore surprised to observe a similar increase in conductance after replacing valinomycin with CCCP. g0 increased under UV illumination (Fig. 4a) by a factor 7.4 ± 0.3 (mean ± SEM of N = 3), closely resembling the behavior of valinomycin–K+. Again, ion-selectivity was preserved, as indicated by the sustained large negative Vr under a nominal 2 unit pH gradient (Fig. 4b). As in the case of valinomycin, P was swiftly modulated by light: triggering the blue laser immediately abolished the UV-induced increase in I, reflecting a swift return to the membrane's trans state (Fig. 4c).

As established for valinomycin, an increase in [S] is the most plausible explanation for the enhancement of g0. Since a shift in KA is unlikely, we propose that the photolipids introduce binding sites for CCCP, with fewer sites available in the trans than in the cis state. This hypothesis can be tested by measuring the surface potential, ϕs. While absolute ϕs measurements are difficult to perform on planar lipid membranes, measurements of transmembrane differences in ϕs, Δϕs, are feasible. These rely on the dependence of membrane capacitance on the difference in boundary potentials, Δϕb, across the bilayer, where Δϕb = Δϕs + Δϕd and Δϕd is the dipole potential difference between the two membrane–water interfaces.

To introduce asymmetry in leaflet composition, we replaced symmetric OptoDArG with 20 wt% 1-stearoyl-2-oxy-4-[4-(4-butylphenylazo)phenyl]butanoyl-sn-glycero-3-phosphocholine (OxyAzoPC) in only one leaflet. Importantly, due to its zwitterionic headgroup, OxyAzoPC does not undergo flip-flop. Measurements revealed that switching from trans to cis decreased Δϕb by ≈6 mV in the presence of CCCP (Fig. S6). Assuming Δϕd remains unchanged, this suggests greater CCCP binding to azobenzene groups in the cis state, consistent with our hypothesis.

To relate the photolipid-induced increase in surface CCCP concentration to its membrane adsorption in the absence of photolipid, we conducted experiments under a pH gradient. We made the following assumptions: (i) protonation/deprotonation reactions at the interface are at equilibrium, as they are faster than membrane transport, (ii) the membrane affinity for charged and neutral forms is equal, since the anion's negative charge remains near the interface,31 and (iii) the pKa of 6.1 is the same in bulk and at the surface.31 At pH 5.0, ≈7% of CCCP is charged; at pH 7.4, ≈95% is charged. Subtracting the 6 mV Δϕs difference (from the difference in Δϕb due to CCCP adsorption to the trans and cis state membrane in the absence of a pH gradient) from the 10 mV Δϕs difference observed across a bilayer with one leaflet at pH 5 and the OxyAzoPC-containing leaflet at pH 7.4 leaves 4 mV. These 4 mV represent ≈90% of CCCP molecules adsorbing without photolipid.

Assuming that ϕs scales with the interfacial concentration of CCCP, we estimate that 20 wt% cis-OxyAzoPC (which carries one azobenzene moiety) alone binds ≈1.5 times more CCCP than a control bilayer lacking photolipid. Accordingly, 20 wt% cis-OptoDArG (with two azobenzene moieties per molecule) may be expected to bind three times more CCCP than the bilayer alone. Together, both lipid-bound and OptoDArG-bound CCCP result in four times an abundance of binding sites compared to control conditions. The observed 7.4-fold light-induced increase in g0 exceeds this value, suggesting that not only binding but also the transport rate may have been increased. One possibility is that OptoDArG–CCCP complexes contribute directly to charge transport. The 4.3-fold increase in molecular mass upon complex formation would reduce ΔGb by nearly a factor of two – an effect that together with the augmented binding site density would be consistent with the observed rise in g0.

Strong photoeffects on proton-selective currents

To maximize the light effect and improve suitability for in vivo studies, we aimed to reduce the dark current (i.e., the current when the photolipid is in its trans state). To this end, we replaced the anionic protonophore CCCP with a cationic protonophore – a weak base that crosses the membrane in its protonated positively-charged form. The rationale is that cationic protonophores have a higher ΔG than anionic ones due to the positive values of ϕd. We selected Nile Blue (NB), a red fluorescent benzophenoxazine dye previously described as a mitochondrial uncoupler.32 Since NB is relatively inefficient as a protonophore, we increased its hydrophobicity by attaching a lipid chain, generating NB-lipid (Fig. 1d). Upon adding NB-lipid to both sides of an OptoDArG-containing membrane, we observed gradual insertion into the bilayer, accompanied by a corresponding increase in membrane conductance, g0 (Fig. S3). The recorded IV curves exhibited a characteristic supralinear shape, consistent with the trapezoidal profile of ΔG.7

Importantly, the relatively large currents in Fig. S3 were recorded in membranes containing OptoDArG. In its absence, currents were much smaller (Fig. 5a), consistent with a large ΔG. Unlike in the CCCP experiments, the presence of OptoDArG was evident even when the bilayer was in the trans state. To clarify whether the increased current was due to additional binding sites provided by the photolipid, we replaced OptoDArG with OxyAzoPC and monitored g0. Importantly, g0 remained nearly unchanged with OxyAzoPC (Fig. 5a), suggesting that the flip-flop capability of OptoDArG33,34 is essential for the conductance increase. These observations can be explained by the formation of a nanoscale complex between OptoDArG and NB-lipid, which flips across the membrane and mediates proton transport (Fig. 5b).


image file: d5nr04234h-f5.tif
Fig. 5 OptoDArG significantly augments the protonophoric activity of NB-lipid and allows its photoregulation. (a) Representative IV curves recorded on PLBs folded from pure E. coli PLE (no NB-lipid), 99 wt% E. coli PLE with 1 wt% NB-lipid (+NB-lipid), 89 wt% E. coli PLE with 10 wt% OxyAzoPC and 1 wt% NB-lipid (+NB-lipid + OxyAzoPC), 79 wt% E. coli PLE, 20 wt% OptoDArG and 1 wt% NB-lipid (+NB-lipid + OptoDArG). (b) g0 was significantly increased only in the presence of both OptoDArG (glycerol and lipid backbone in black, azobenzene moieties in purple) and NB-lipid (green), indicating a decrease in ΔG. No flip-flop is observed when OptoDArG is substituted for OxyAzoPC. (c) Voltage–clamp current recordings with PLBs containing 20 wt% OptoDArG and 1 wt% NB-lipid. The solution contained 15 mM KCl, 10 mM HEPES pH 7.4. Recordings were made as in Fig. 2b. In this record, exceptionally high on–off current regulation by light (IUV/Iblue > 200) was achieved. (d) IV curves constructed from current records as described in Fig. 2c. Conditions were symmetric (100 mM KCl, 20 mM MES, pH 5 at both sides; closed symbols) and asymmetric (pH at side 2 increased to 7; open symbols). NB-lipid currents are proton-selective. (e) Even at physiological salt concentrations (150 mM NaCl, 20 mM TRIS, pH 9), H+-selectivity is retained. This can be appreciated from the large negative-going shift in Vr upon reducing pH in compartment 1 by the addition of acid. (f) Recordings made as in panel c whereby the duration of UV light exposure was reduced to 1 ms (V ranged from 110 mV to −110 mV). Even short pulses of UV light can effectively regulate membrane proton permeability.

Upon UV illumination of OptoDArG and NB-lipid-containing membranes, we observed a >200-fold increase in g0 and thus H+ permeability (Fig. 5c). Despite notable variability across replicates (e.g., freshly prepared chambers and different lipid mixtures; Fig. S5a), the dark current remained generally low, and the light-induced increase consistently high (g0 = 4.8 ± 2.1 nS, fold increase in g0 with UV light: 85 ± 38, mean ± SEM of N = 5).

The increase in g0 upon UV exposure is, at least in part, due to new NB-lipid binding sites exposed by azobenzene moieties. Supporting evidence comes from the change in Δϕb in membranes with OxyAzoPC in only one leaflet (Fig. S6). Since OxyAzoPC does not flip-flop, Δϕb remains constant over time. Despite more carrier molecules, no significant increase in g0 is observed (Fig. 5a). In contrast, OptoDArG induces a rise in g0, suggesting that both binding partners – the azobenzene moiety and NB-lipid – must cross the membrane together. Only then does the increased interfacial concentration of protonated NB-lipid enhance g0 (Fig. 5c).

Experiments carried out with a transmembrane pH gradient confirmed that the current is proton-selective (Fig. 5d). Furthermore, this selectivity remained intact even in the presence of physiological salt concentrations (150 mM NaCl in Fig. 5e; 150 mM KCl in Fig. S4). Finally, even short UV light pulses (1 ms long) resulted in a sizable increment in I (Fig. 5f); this may be important for cell applications as it reduces the amount of energy delivered by light.

Discussion

We demonstrated that isomerization of photoswitchable bilayers elicits effects beyond typical changes in bulk properties such as membrane thickness. This nanoscale conformational change photoregulates interfacial chemical reactions and, consequently, membrane transport. The substantial enhancements in carrier-mediated ion flux – up to two orders of magnitude – arise from increased interfacial concentrations of charged carriers and, in certain cases, additional transport rate amplifications mediated by light-responsive nanoscale complexes.

Interfacial concentration modulation is governed by (i) nanoscale changes in lipid packing due to photoisomerization and (ii) specific, conformation-dependent interactions between azobenzene moieties and carriers that form transient nanoscale complexes. For photolipid-enabled transport regulation, exploiting these phenomena is promising: photoisomerization increases the number of interfacial binding sites, notably those formed by cis azobenzene moieties. Recruitment of additional carrier molecules from bulk to membrane is evidenced by alteration in Δϕb upon switching OxyAzoPC from trans to cis. For OptoDArG, we observed a fourfold CCCP concentration increase. Together with the halving of ΔGb, this is largely consistent with the roughly sevenfold increase in CCCP-mediated g0 with cis-OptoDArG.

The larger increase in g0 with NB-lipid by up to two orders of magnitude cannot be explained by additional interfacial binding sites alone. OxyAzoPC provides binding sites yet does not substantially raise conductivity, indicating that specific organization and complexation are required. Robust proton-selective currents emerged only when OptoDArG was present alongside NB-lipid, implicating a second mechanism: enhanced proton transport via reduction in ΔG. We propose a mobile OptoDArG–NB-lipid complex that flip-flops across the bilayer, a process facilitated by cis-OptoDArG–induced thinning and reduced packing (Fig. 5b).

Two factors contribute to ΔG reduction: (i) the nanoscale 1[thin space (1/6-em)]:[thin space (1/6-em)]1 OptoDArG–NB-lipid complex increases the effective size of the transporting entity, reducing ΔGb by about one third; (ii) NB-lipid lowers Δϕb (Fig. 5b). Therefore, NB-lipid dipoles align antiparallel to membrane dipoles (the positive charge points toward the aqueous solution), decreasing Δϕd sufficiently to offset the complex's effect on Δϕs. Similar divergent effects on Δϕd and Δϕs are known for verapamil, whose positive charge also faces the aqueous phase while the negative pole points inward.27 The resulting decrease in Δϕb lowers ΔGd and thus the overall ΔG.

Accordingly, the photoinduced increase in proton-selective current with OptoDArG and NB-lipid reflects the combined action of: (i) decreased lipid packing in the cis state, (ii) increased density of interfacial binding sites provided by cis azobenzenes, and (iii) a reduced ΔG via Born energy and dipole potential modulation.

Notably, the combination of NB-lipid and photolipids partially outperforms channelrhodopsins (ChR), an alternative method for generating light-switchable proton currents.35–39 At neutral pH, the photocurrents generated are comparable in magnitude (Fig. 5c) to those elicited by the human proton channel HV1 or ChR in transfected cells.5,40 As in the case of HV1 or ChR2, the current is highly selective for protons. In contrast to ChR2, where the ratio of proton to sodium permeability, PH+/PNa+, of 2 × 106 to 6 × 106 yields a substantial Na+ component at neutral pH in mammalian brain,39 NB-lipid–containing cis-state membranes exhibit negligible salt-ion contributions even at high salinity (Fig. 5e).

Our all-chemical, nanoscale photolipid platform enables millisecond-scale, light-dependent regulation of well-established, highly selective carriers, delivering large currents, submillisecond photoresponse, tunable ion scope, and a single-photon action spectrum extendable from UV/Vis to NIR/SWIR.41,42 Red-shifted azobenzene photoswitches and photolipids suitable for red and near-infrared actuation are already available.43–46 These attributes differentiate it from prior strategies: (i) photopharmacological control of drug conformation by light6,10 that typically use orthosteric or allosteric ligands to gate protein activity (e.g., ion channels and other membrane transporters),42,47 (ii) molecular machines where ionophores are directly photosensitized48 where light-dependent currents are generated and ionophores per se are modified with light-sensitive moieties, (iii) rotary molecular motors which have been reported to increase membrane ion permeability upon irradiation,49,50 but have been shown to act at least partially through irreversible photodynamic membrane lipid peroxidation51 rather than drilling,52 (iv) artificial supramolecular channels,53,54 and (v) light-based approaches at regulating mechanosensitive, voltage-sensitive and other membrane-embedded channels by alterations in bilayer mechanical properties.12,13,55–57

Additionally, while the ChR-based optogenetic approach35–39 requires genetic transfection to achieve selective ion currents in response to incident light, our nanoscale chemical approach avoids this complication since both ion carriers and photolipids12,58 can be administered acutely via solution. This modular control complements protein-based optogenetics and should generalize to Ca2+, Na+, and K+ carriers, paralleling ChR engineering,38,39 but with faster, rational design cycles and broader spectral tunability.41,42

We envision photolipid-regulated carriers as a convenient and general nanoscale chemical toolkit for dynamic, light-based regulation of ion permeability in biological and synthetic cells, and in artificial neuronal systems. More broadly, photolipid-based optical control of interfacial nanostructure and reactivity should extend beyond ion transport, suggesting that the potential of these photoswitchable lipid reagents is greater than previously appreciated.

Materials and methods

Materials for planar lipid bilayer experiments

E. coli Polar Lipid Extract (PLE, item no. 100600) was obtained from Avanti Polar Lipids (distributed by Merck) and kept at −80 °C. OptoDArG was synthesized by the group of Dr Glasnov as described previously.59 Lipid aliquots and mixtures were prepared within amber glass micro reaction vials from lipids dissolved in chloroform. Prior to storage at −80 °C, solvent was evaporated by a mild vacuum gradient (Rotavapor, Büchi Labortechnik AG) and the dried lipids were flooded with argon. All aqueous buffers used in the PLB experiments were freshly prepared from laboratory-grade dry substances (supplied by VWR, Merck, or Fisher Scientific) dissolved in ultrapure water (>18 MΩ cm, Milli-Q water purification system) and pH-adjusted using a daily-calibrated pH meter (FiveEasy, Mettler Toledo). CCCP (carbonyl cyanide m-chlorophenylhydrazone, 98%, Thermo Scientific) and valinomycin were kept as stocks in DMSO. Sodium tetraphenylborate (>99.5%, T25402, Sigma-Aldrich) was added from a stock solution in ethanol. NB-lipid was synthesized in a parallel study, with synthesis and characterization given there as molecule S43.42 NB-lipid was kept in a dried state at −80 °C and aliquots were prepared in DMSO prior to measurement.

Horizontal planar lipid bilayer experiments

Planar lipid bilayer (PLB) experiments with laser irradiation for rapid photoisomerization were conducted as recently described.12 A schematic of the setup is shown in Fig. 2a. Solvent-depleted horizontal PLBs (specific capacitance 0.75 µF cm−2) were folded from lipids spread on top of aqueous buffer in the lower and upper compartment of a custom-made chamber assembly made of PTFE.60,61

First, an aperture of around 70 µm in diameter in 25 µm-thick PTFE foil (Goodfellow GmbH) was created by high voltage discharge – this prepares the septum separating the macroscopic compartments. In this study, diameters were between 70 µm to 85 µm, with exceptions denoted explicitly. The PLB diameters given in the main text refer to the size of this aperture. After the septum was treated with 0.6 vol% hexadecane in hexane, hexane was allowed to evaporate for >1 h. The residual hexadecane facilitates the solvent annulus or torus that later laterally anchors the PLB within the aperture.62 The septum was attached by silicon paste to the lower side of the upper compartment of the chamber assembly. Lipids at the air–water interfaces were prepared by applying lipid mixtures dissolved in hexane at a concentration of 10 mg mL−1 onto both aqueous interfaces. After hexane had evaporated, a horizontal PLB was folded by rotation of the upper compartment of the chamber assembly.

A 30 mm-diameter cover glass (No. 1, Assistent, Hecht Glaswarenfabrik GmbH & Co KG) fixed with a threaded PTFE ring comprised the bottom of the lower compartment. The chamber assembly was installed on the sample stage of an Olympus IX83 inverted microscope equipped with an iXon 897 E EMCCD (Andor, Oxford Instruments Group). The chamber holder was equipped with screws for fine translation of the upper compartment in z direction to position the horizontal PLB within the working distance of a 40×/1.30 NA infinity-corrected plan fluorite oil immersion objective (UPLFLN40XO, Olympus) or a 40×/0.65 NA infinity-corrected plan achromat air objective (PLN40X, Olympus). The motorized microscope and real-time controller (U-RTC, Olympus) used for synchronizing lasers and electrophysiological acquisition were controlled using the proprietary cellSens software (Olympus).

For electrical measurements, a Ag/AgCl electrode with agar salt bridge containing 0.5 M KCl was put into each compartment and connected to the headstage of an EPC 9 patch-clamp amplifier (HEKA Elektronik, Harvard Bioscience). Headstage and chamber assembly were housed in a Faraday cage. Voltage-clamp measurements were conducted using PATCHMASTER 2x91 software (HEKA Elektronik, Harvard Biosciences). Current was analogously filtered at 10 kHz by a combination of Bessel filters and acquired at 50 kHz. Amplifier offsets were corrected by subtracting the average current recorded at V = 0 mV under symmetric conditions. Data recorded with PATCHMASTER was exported, analyzed, and graphed using Mathematica 14 (Wolfram Research) and OriginPro 2024 (OriginLab Corporation).

Rapid photoisomerization of photolipids embedded in horizontal PLBs was achieved by exposure to blue (488 nm diode laser, iBEAM-SMART-488-S-HP, TOPTICA Photonics) and UV laser light (375 nm diode laser, iBEAM-SMART-375-S, TOPTICA Photonics). Both lasers were digitally modulated and separately focused into the back-focal plane of the objective via the ZT488/640rpc main dichroic mirror (Chroma). The diameter of the blue laser profile at the sample stage was ≈58 µm (1/e2) whilst the UV laser profile spanned roughly 150–200 µm (its shape was less defined owing to the absence of a spatial filter). At a software-set output power of 200 mW (blue) and 70 mW (UV), ≈20–30 mW (blue and UV) exited the microscope objective depending on current alignment, determined by a photodiode (S120VC, Thorlabs). For convenience, we use the notation “cis” and “trans” to refer to PLBs containing mostly cis or mostly trans photolipids (corresponding to UV and blue light-evoked photostationary states).

Vertical planar lipid bilayer experiments

Vertical PLBs were folded in a similar manner to the description above and as given in ref. 13. The Faraday cage was equipped with a magnetic stirrer positioned underneath the PTFE chamber, which allowed the aqueous compartments on both sides of the vertical PLB to be stirred by magnetic PTFE-coated stir bars. Ag/AgCl electrodes with agar salt bridges were used. The recordings were made with an EPC 10 patch-clamp amplifier (HEKA Elektronik, Harvard Bioscience).

Biexponential function fits

To extract rate information from the time course of current upon light exposure, we fitted several sets of curves with the following bi-exponential equation:
 
image file: d5nr04234h-t3.tif(3)
where I0 denotes basal current, ΔI1 and ΔI2 the increment in I associated with growth at rate 1/τ1 and 1/τ2. Typically, several curves were fit globally (Mathematica resource function MultiNonlinearModelFit) and curves recorded at lower voltages (|V| ≤ 30 mV) were neglected.

Asymmetric PLBs and boundary potential measurements

Horizontal asymmetric PLBs were essentially folded as described above, with the distinction that the interfacial lipids applied from lipid mixtures in hexane differed between the two compartments of the chamber.63 Asymmetry here refers to a difference in the lipid composition of the two leaflets forming the bilayer.

The difference in boundary potential between the two sides of the membrane was determined by measuring membrane capacitance, Cm, at different applied transmembrane voltages, V, using the EPC-9 patch-clamp amplifier. Cm was measured using the software lock-in amplifier implemented in PATCHMASTER (configuration: “Sine + DC” method with computer calibration, 20 mV peak amplitude, 833 Hz, 30 points per cycle, acquisition at 25 kHz). The DC voltage offset (V) was varied between −100 and +100 mV at 20 mV intervals. When the externally applied voltage cancels the intramembrane electric field – which corresponds to the difference in boundary potential of the two sides of the membrane – Cm is at its minimum.64,65 To infer this minimum from the parabolic dependence of membrane capacitance on V, the obtained CmV data was fit by the following equation:

Cm(V) = aV2 + bV + c
where a, b, and c are fit constants. The vertex of the parabola was calculated as –b/2a.

Author contributions

JP, RY and PP conceptualized the research. RY conducted the experiments and with JP analyzed the obtained data. JP developed the methodology. JP and PP wrote the manuscript. TG synthesized OptoDArG. OTS synthesized NB-lipid and OxyAzoPC. PP acquired funding and supervised the research. All authors contributed to the editing of the manuscript.

Conflicts of interest

The authors declare no competing interests.

Data availability

All data supporting the findings of this study are included within the manuscript and its supplementary information (SI). Datasets have been uploaded to Zenodo at https://doi.org/10.5281/zenodo.17864263. See DOI: https://doi.org/10.1039/d5nr04234h.

There are no restrictions on data availability beyond standard privacy and ethical considerations.

Acknowledgements

This research was funded in whole by the Austrian Science Fund (FWF) grants P36399 and P34826 to Peter Pohl.

References

  1. B. Hille, Ion Channels of Excitable Membranes, Sinauer Associates, Inc., Sunderland, Massachusetts, 3 edn, 2001 Search PubMed.
  2. D. G. Nicholls and S. Ferguson, Bioenergetics, Academic Press, London, 4 edn, 2013 Search PubMed.
  3. E. Klotzsch, A. Smorodchenko, L. Lofler, R. Moldzio, E. Parkinson, G. J. Schutz and E. E. Pohl, Proc. Natl. Acad. Sci. U. S. A., 2015, 112, 130–135 CrossRef CAS.
  4. F. Zhang, L.-P. Wang, M. Brauner, J. F. Liewald, K. Kay, N. Watzke, P. G. Wood, E. Bamberg, G. Nagel and A. Gottschalk, Nature, 2007, 446, 633–639 CrossRef CAS PubMed.
  5. G. Nagel, D. Ollig, M. Fuhrmann, S. Kateriya, A. M. Musti, E. Bamberg and P. Hegemann, Science, 2002, 296, 2395–2398 CrossRef CAS.
  6. K. Hüll, J. Morstein and D. Trauner, Chem. Rev., 2018, 118, 10710–10747 CrossRef.
  7. C. Hannesschlaeger, A. Horner and P. Pohl, Chem. Rev., 2019, 119, 5922–5953 CrossRef CAS PubMed.
  8. A. Parsegian, Nature, 1969, 221, 844–846 CrossRef CAS.
  9. P. Läuger, Science, 1972, 178, 24–30 CrossRef PubMed.
  10. W. A. Velema, W. Szymanski and B. L. Feringa, J. Am. Chem. Soc., 2014, 136, 2178–2191 CrossRef CAS PubMed.
  11. F. A. Jerca, V. V. Jerca and R. Hoogenboom, Nat. Rev. Chem., 2022, 6, 51–69 CrossRef PubMed.
  12. C. A. Z. Bassetto, J. Pfeffermann, R. Yadav, S. Strassgschwandtner, T. Glasnov, F. Bezanilla and P. Pohl, Nat. Commun., 2024, 15, 1139 CrossRef.
  13. J. Pfeffermann, B. Eicher, D. Boytsov, C. Hannesschlaeger, T. R. Galimzyanov, T. N. Glasnov, G. Pabst, S. A. Akimov and P. Pohl, J. Photochem. Photobiol., B, 2021, 224, 112320 CrossRef CAS PubMed.
  14. H. Brockmann and G. Schmidt-Kastner, Chem. Ber., 1955, 88, 57–61 CrossRef CAS.
  15. S. B. Hladky, J. C. Leung and W. J. Fitzgerald, Biophys. J., 1995, 69, 1758–1772 CrossRef CAS PubMed.
  16. S. Krasne, G. Eisenman and G. Szabo, Science, 1971, 174, 412–415 CrossRef CAS.
  17. E. Orbach and A. Finkelstein, J. Gen. Physiol., 1980, 75, 427–436 CrossRef CAS PubMed.
  18. F. Zocher, D. van der Spoel, P. Pohl and J. S. Hub, Biophys. J., 2013, 105, 2760–2770 CrossRef CAS PubMed.
  19. R. F. Flewelling and W. L. Hubbell, Biophys. J., 1986, 49, 541–552 CrossRef CAS PubMed.
  20. R. Benz, P. Läuger and K. Janko, Biochim. Biophys. Acta, 1976, 455, 701–720 CrossRef CAS.
  21. J. P. Dilger, S. G. A. McLaughlin, T. J. McIntosh and S. A. Simon, Science, 1979, 206, 1196–1198 CrossRef CAS PubMed.
  22. I. V. Khavrutskii, A. A. Gorfe, B. Lu and J. A. McCammon, J. Am. Chem. Soc., 2009, 131, 1706–1716 CrossRef CAS PubMed.
  23. O. S. Andersen and M. Fuchs, Biophys. J., 1975, 15, 795–830 CrossRef CAS.
  24. A. Ebert, C. Hannesschlaeger, K.-U. Goss and P. Pohl, Biophys. J., 2018, 115, 1931–1941 CrossRef CAS.
  25. K. Gawrisch, D. Ruston, J. Zimmerberg, V. A. Parsegian, R. P. Rand and N. Fuller, Biophys. J., 1992, 61, 1213–1223 CrossRef CAS PubMed.
  26. U. Peterson, D. A. Mannock, R. N. A. H. Lewis, P. Pohl, R. N. McElhaney and E. E. Pohl, Chem. Phys. Lipids, 2002, 117, 19–27 CrossRef CAS.
  27. E. E. Pohl, A. V. Krylov, M. Block and P. Pohl, Biochim. Biophys. Acta, 1998, 1373, 170–178 CrossRef CAS PubMed.
  28. G. S. Hartley and R. J. W. Le Fèvre, J. Chem. Soc., 1939, 531–535,  10.1039/jr9390000531.
  29. E. E. Pohl, U. Peterson, J. Sun and P. Pohl, Biochemistry, 2000, 39, 1834–1839 CrossRef CAS PubMed.
  30. R. Benz, O. Fröhlich and P. Läuger, Biochim. Biophys. Acta, 1977, 464, 465–481 CrossRef CAS PubMed.
  31. J. Kasianowicz, R. Benz and S. McLaughlin, J. Membr. Biol., 1984, 82, 179–190 CrossRef CAS.
  32. M. S. Mai and W. S. Allison, Arch. Biochem. Biophys., 1983, 221, 467–476 CrossRef CAS PubMed.
  33. F. Ogushi, R. Ishitsuka, T. Kobayashi and Y. Sugita, Chem. Phys. Lett., 2012, 522, 96–102 CrossRef CAS.
  34. W. D. Bennett and D. P. Tieleman, J. Lipid Res., 2012, 53, 421–429 CrossRef CAS PubMed.
  35. E. S. Boyden, F. Zhang, E. Bamberg, G. Nagel and K. Deisseroth, Nat. Neurosci., 2005, 8, 1263–1268 CrossRef CAS PubMed.
  36. K. Deisseroth, Nat. Methods, 2011, 8, 26–29 CrossRef CAS PubMed.
  37. S. Kleinlogel, U. Terpitz, B. Legrum, D. Gökbuget, E. S. Boyden, C. Bamann, P. G. Wood and E. Bamberg, Nat. Methods, 2011, 8, 1083–1088 CrossRef CAS PubMed.
  38. P. Hegemann and G. Nagel, EMBO Mol. Med., 2013, 5, 173–176 CrossRef CAS.
  39. K. Deisseroth and P. Hegemann, Science, 2017, 357 DOI:10.1126/science.aan5544.
  40. D. Boytsov, S. Brescia, G. Chaves, S. Koefler, C. Hannesschlaeger, C. Siligan, N. Goessweiner-Mohr, B. Musset and P. Pohl, Small, 2023, 19, e2205968 CrossRef PubMed.
  41. B. Baumgartner, V. Glembockyte, R. Mayer, A. Gonzalez-Hernandez, R. Kindler, A. Valavalkar, A. Wiegand, A. Müller-Deku, L. Grubert and F. Steiner, ChemRxiv, 2023,  DOI:10.26434/chemrxiv-2023-37sv4.
  42. B. Baumgartner, V. Glembockyte, A. J. Gonzalez-Hernandez, A. Valavalkar, R. J. Mayer, L. L. Fillbrook, A. Müller-Deku, J. Zhang, F. Steiner and C. Gross, ChemRxiv, 2024,  DOI:10.26434/chemrxiv-2024-vm4n3.
  43. M. Dong, A. Babalhavaeji, S. Samanta, A. A. Beharry and G. A. Woolley, Acc. Chem. Res., 2015, 48, 2662–2670 CrossRef CAS.
  44. A. Kerckhoffs, K. E. Christensen and M. J. Langton, Chem. Sci., 2022, 13, 11551–11559 RSC.
  45. S. D. Pritzl, D. B. Konrad, M. F. Ober, A. F. Richter, J. A. Frank, B. Nickel, D. Trauner and T. Lohmüller, Langmuir, 2022, 38, 385–393 CrossRef CAS.
  46. N. Chander, J. Morstein, J. S. Bolten, A. Shemet, P. R. Cullis, D. Trauner and D. Witzigmann, Small, 2021, 17, 2008198 CrossRef CAS PubMed.
  47. M. Müller, K. Niemeyer, N. K. Ojha, S. A. Porav, D. Vinayagam, N. Urban, F. Büchau, K. Oleinikov, M. Makke, C. C. Bauer, A. V. Johnson, S. P. Muench, F. Zufall, D. Bruns, Y. Schwarz, S. Raunser, T. Leinders-Zufall, R. S. Bon, M. Schaefer and O. Thorn-Seshold, bioRxiv, 2024,  DOI:10.1101/2024.07.12.602451.
  48. T. Johnson, Molecular machines for controlling transmembrane ion transport, PhD thesis, University of Oxford,  DOI:10.5287/ora-ngbdgbqkz.
  49. V. García-López, F. Chen, L. G. Nilewski, G. Duret, A. Aliyan, A. B. Kolomeisky, J. T. Robinson, G. Wang, R. Pal and J. M. Tour, Nature, 2017, 548, 567–572 CrossRef PubMed.
  50. Y. Qutbuddin, A. Guinart, S. Gavrilović, K. Al Nahas, B. L. Feringa and P. Schwille, Adv. Mater., 2024, 36, e2311176 CrossRef.
  51. A. Guinart, D. Doellerer, Y. Qutbuddin, H. Zivkovic, C. Branca, D. Hrebik, P. Schwille and B. L. Feringa, Langmuir, 2025, 41, 3961–3970 CrossRef CAS PubMed.
  52. A. M. Firsov, J. Pfeffermann, A. S. Benditkis, T. I. Rokitskaya, A. S. Kozlov, E. A. Kotova, A. A. Krasnovsky, P. Pohl and Y. N. Antonenko, J. Photochem. Photobiol., B, 2023, 239, 112633 CrossRef CAS.
  53. M. M. Tedesco, B. Ghebremariam, N. Sakai and S. Matile, Angew. Chem., 1999, 111, 523–526 CrossRef.
  54. S. Bhosale, A. L. Sisson, P. Talukdar, A. Fürstenberg, N. Banerji, E. Vauthey, G. Bollot, J. Mareda, C. Röger, F. Würthner, N. Sakai and S. Matile, Science, 2006, 313, 84–86 CrossRef CAS.
  55. F. Crea, A. Vorkas, A. Redlich, R. Cruz, C. Shi, D. Trauner, A. Lange, R. Schlesinger and J. Heberle, Front. Mol. Biosci., 2022, 9, 905306 CrossRef CAS PubMed.
  56. R. Yadav, J. Pfeffermann, N. Goessweiner-Mohr, T. Glasnov, S. A. Akimov and P. Pohl, Biomolecules, 2025, 15, 744 CrossRef CAS.
  57. J. E. Bos, N. Duindam, T. J. Kock, M. A. Siegler and S. J. Wezenberg, Angew. Chem., 2025, 137, e202420232 CrossRef.
  58. T. Leinders-Zufall, U. Storch, M. Mederos y Schnitzler, N. K. Ojha, K. Koike, T. Gudermann and F. Zufall, STAR Protoc., 2021, 2, 100527 CrossRef CAS PubMed.
  59. M. Lichtenegger, O. Tiapko, B. Svobodova, T. Stockner, T. N. Glasnov, W. Schreibmayer, D. Platzer, G. G. La Cruz, S. Krenn, R. Schober, N. Shrestha, R. Schindl, C. Romanin and K. Groschner, Nat. Chem. Biol., 2018, 14, 396–404 CrossRef CAS PubMed.
  60. M. Montal and P. Mueller, Proc. Natl. Acad. Sci. U. S. A., 1972, 69, 3561–3566 CrossRef CAS PubMed.
  61. A. Saitov, S. A. Akimov, T. R. Galimzyanov, T. Glasnov and P. Pohl, Phys. Rev. Lett., 2020, 124, 108102 CrossRef CAS PubMed.
  62. S. H. White, D. C. Petersen, S. Simon and M. Yafuso, Biophys. J., 1976, 16, 481–489 CrossRef CAS.
  63. A. Horner, S. A. Akimov and P. Pohl, Phys. Rev. Lett., 2013, 110, 268101 CrossRef.
  64. O. Alvarez and R. Latorre, Biophys. J., 1978, 21, 1–17 CrossRef CAS PubMed.
  65. P. Pohl, T. I. Rokitskaya, E. E. Pohl and S. M. Saparov, Biochim. Biophys. Acta, 1997, 1323, 163–172 CrossRef CAS.

Footnote

These authors contributed equally to this work.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.